The Netherlands
The company functions as a holding company, with its shares listed on SIX in Zurich, Switzerland. IGEA Pharma N.V. specializes in transforming natural resources into functional food, food supplements, and high-tech products for the cosmetic and pharma industries, while also focusing on health-tech and med-tech products and devices.
As of 15 April 2021, the company received a €2.00M Post-IPO Debt investment from Negma Group. It operates development, production, and commercialization entities in Italy, Switzerland, and the United States. The company's current focal points include health prevention and nutraceutical solutions with a focus on hemp, policosanol, and ikuvia extracts based on CO2 supercritical extraction, as well as preventative health-tech products for Alzheimer’s and diabetes. Additionally, they develop med-tech products for air and inanimate environmental surface sanitization with aerosol technology-based devices.
